115 related articles for article (PubMed ID: 10089769)
1. [The hepatitis C virus: after the track of the human immunodeficiency virus].
Pérez-Olmeda M; Rodríguez-Rosado R; García-Samaniego J; Soriano V
Rev Clin Esp; 1999 Jan; 199(1):5-7. PubMed ID: 10089769
[No Abstract] [Full Text] [Related]
2. Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection.
Fialaire P; Payan C; Vitour D; Chennebault JM; Loison J; Pichard E; Lunel F
J Infect Dis; 1999 Aug; 180(2):574-5. PubMed ID: 10395889
[No Abstract] [Full Text] [Related]
3. Understanding human immunodeficiency virus type 1 and hepatitis C virus coinfection.
Tan YJ; Lim SG; Hong W
Curr HIV Res; 2006 Jan; 4(1):21-30. PubMed ID: 16454708
[TBL] [Abstract][Full Text] [Related]
4. HIV and hepatitis C co-infection.
Jones R; Dunning J; Nelson M
Int J Clin Pract; 2005 Sep; 59(9):1082-7. PubMed ID: 16115185
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life.
Cacoub P; Rosenthal E; Halfon P; Sene D; Perronne C; Pol S
J Viral Hepat; 2006 Oct; 13(10):678-82. PubMed ID: 16970599
[TBL] [Abstract][Full Text] [Related]
6. Release of virus from lymphoid tissue affects human immunodeficiency virus type 1 and hepatitis C virus kinetics in the blood.
Müller V; Marée AF; De Boer RJ
J Virol; 2001 Mar; 75(6):2597-603. PubMed ID: 11222682
[TBL] [Abstract][Full Text] [Related]
7. Treatment for hepatitis C in patients infected with human immunodeficiency virus.
Fernández I; Muñoz R; Solís-Herruzo JA
Rev Esp Enferm Dig; 2003 Apr; 95(4):287-91, 282-6. PubMed ID: 12826005
[No Abstract] [Full Text] [Related]
8. The design of drugs for HIV and HCV.
De Clercq E
Nat Rev Drug Discov; 2007 Dec; 6(12):1001-18. PubMed ID: 18049474
[TBL] [Abstract][Full Text] [Related]
9. Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection.
Cooper CL; Cameron DW
Clin Infect Dis; 2002 Oct; 35(7):873-9. PubMed ID: 12228825
[TBL] [Abstract][Full Text] [Related]
10. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic aspects of human immunodeficiency virus, hepatitis B and C coinfection].
Bani-Sadr F
Gastroenterol Clin Biol; 2003 May; 27(5):528-33. PubMed ID: 12843917
[No Abstract] [Full Text] [Related]
12. Cellular and molecular interactions in coinfection with hepatitis C virus and human immunodeficiency virus.
Roe B; Hall WW
Expert Rev Mol Med; 2008 Oct; 10():e30. PubMed ID: 18928579
[TBL] [Abstract][Full Text] [Related]
13. HIV and hepatitis C coinfection.
Matthews GV; Dore GJ
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
[TBL] [Abstract][Full Text] [Related]
14. Interaction between HIV-1 and HCV infections: towards a new entity?
Winnock M; Salmon-Céron D; Dabis F; Chêne G
J Antimicrob Chemother; 2004 Jun; 53(6):936-46. PubMed ID: 15117928
[TBL] [Abstract][Full Text] [Related]
15. HIV and hepatitis C coinfection.
Matthews GV; Rockstroh J
Curr Opin HIV AIDS; 2011 Nov; 6(6):449-50. PubMed ID: 22001889
[No Abstract] [Full Text] [Related]
16. GB virus type C-driven protection in HIV/HCV coinfection: possible role of interferon gamma and dendritic cell activation.
Martini F; Sacchi A; Lalle E; Castilletti C; D'Offizi G; Abbate I; Capobianchi MR
Gastroenterology; 2008 May; 134(5):1631-3; author reply 1633. PubMed ID: 18471541
[No Abstract] [Full Text] [Related]
17. Impact of human immunodeficiency virus infection in patients infected with the hepatitis C virus.
Valle Tovo C; Alves de Mattos A; Ribeiro de Souza A; Ferrari de Oliveira Rigo J; Lerias de Almeida PR; Galperim B; Riegel Santos B
Liver Int; 2007 Feb; 27(1):40-6. PubMed ID: 17241379
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis C virus genotype 4: epidemiology and treatment].
Castera L; Morice Y; Grando V; Bon C; Dény P; Roulot D
Gastroenterol Clin Biol; 2003 Jun; 27(6-7):596-604. PubMed ID: 12910223
[No Abstract] [Full Text] [Related]
19. Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV testing center in Brazil.
Pereira GA; Stefani MM; Martelli CM; Turchi MD; Siqueira EM; Carneiro MA; Martins RM
J Med Virol; 2006 Jun; 78(6):719-23. PubMed ID: 16628586
[TBL] [Abstract][Full Text] [Related]
20. Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy.
Ragni MV; Bontempo FA
J Infect Dis; 1999 Dec; 180(6):2027-9. PubMed ID: 10558963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
